BRPF1
Basic information
Region (hg38): 3:9731729-9748019
Links
Phenotypes
GenCC
Source:
- intellectual developmental disorder with dysmorphic facies and ptosis (Strong), mode of inheritance: AD
- intellectual developmental disorder with dysmorphic facies and ptosis (Strong), mode of inheritance: AD
- intellectual developmental disorder with dysmorphic facies and ptosis (Strong), mode of inheritance: AD
- intellectual developmental disorder with dysmorphic facies and ptosis (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Intellectual disability disorder with dysmorphic facies and ptosis (IDDDFP) | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 27939639; 27939640 |
ClinVar
This is a list of variants' phenotypes submitted to
- Intellectual developmental disorder with dysmorphic facies and ptosis (23 variants)
- not provided (20 variants)
- Inborn genetic diseases (11 variants)
- BRPF1-related disorder (2 variants)
- Global developmental delay (1 variants)
- Intellectual disability (1 variants)
- Sudden unexplained death in childhood (1 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BRPF1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 33 | 40 | ||||
missense | 185 | 25 | 218 | |||
nonsense | 18 | 22 | ||||
start loss | 2 | |||||
frameshift | 26 | 11 | 39 | |||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
splice region | 6 | 1 | 7 | |||
non coding | 2 | |||||
Total | 47 | 25 | 194 | 58 | 9 |
Highest pathogenic variant AF is 0.00000657
Variants in BRPF1
This is a list of pathogenic ClinVar variants found in the BRPF1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-9734142-T-G | Intellectual developmental disorder with dysmorphic facies and ptosis | Likely pathogenic (May 01, 2020) | ||
3-9734143-G-A | Pathogenic (May 29, 2019) | |||
3-9734150-G-C | Uncertain significance (Jan 02, 2024) | |||
3-9734158-T-C | Likely benign (Feb 01, 2023) | |||
3-9734166-CTT-C | Inborn genetic diseases | Pathogenic (Mar 02, 2023) | ||
3-9734187-C-T | Intellectual developmental disorder with dysmorphic facies and ptosis | Uncertain significance (Dec 19, 2018) | ||
3-9734192-A-G | Uncertain significance (May 12, 2024) | |||
3-9734195-C-T | Inborn genetic diseases | Uncertain significance (Feb 07, 2023) | ||
3-9734203-C-T | Intellectual developmental disorder with dysmorphic facies and ptosis | Benign/Likely benign (Aug 06, 2021) | ||
3-9734207-T-C | Intellectual developmental disorder with dysmorphic facies and ptosis | Likely pathogenic (Jan 01, 2019) | ||
3-9734225-C-T | Pathogenic (Mar 27, 2024) | |||
3-9734229-A-G | Intellectual developmental disorder with dysmorphic facies and ptosis | Uncertain significance (May 21, 2020) | ||
3-9734243-T-TA | Intellectual developmental disorder with dysmorphic facies and ptosis | Pathogenic (Feb 09, 2017) | ||
3-9734262-A-C | BRPF1-related disorder | Uncertain significance (Jul 02, 2024) | ||
3-9734281-C-T | Likely benign (Feb 01, 2025) | |||
3-9734335-G-A | BRPF1-related disorder | Benign (Aug 16, 2018) | ||
3-9734336-C-T | Intellectual developmental disorder with dysmorphic facies and ptosis | Likely benign (Mar 25, 2024) | ||
3-9734337-G-A | BRPF1-related disorder | Uncertain significance (Aug 12, 2024) | ||
3-9734339-C-T | Pathogenic (Aug 13, 2024) | |||
3-9734348-C-G | Inborn genetic diseases | Uncertain significance (Aug 20, 2024) | ||
3-9734348-C-T | Inborn genetic diseases | Likely benign (Apr 23, 2024) | ||
3-9734358-A-G | Intellectual developmental disorder with dysmorphic facies and ptosis | Uncertain significance (Jun 24, 2022) | ||
3-9734367-C-T | Intellectual developmental disorder with dysmorphic facies and ptosis | Uncertain significance (Dec 04, 2018) | ||
3-9734381-G-A | Intellectual developmental disorder with dysmorphic facies and ptosis | Uncertain significance (Dec 27, 2019) | ||
3-9734388-A-T | Inborn genetic diseases | Uncertain significance (Aug 20, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BRPF1 | protein_coding | protein_coding | ENST00000383829 | 13 | 16290 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000459 | 125741 | 0 | 7 | 125748 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.83 | 464 | 761 | 0.609 | 0.0000498 | 8011 |
Missense in Polyphen | 170 | 383.36 | 0.44344 | 4004 | ||
Synonymous | -0.714 | 307 | 291 | 1.05 | 0.0000177 | 2387 |
Loss of Function | 6.17 | 4 | 52.1 | 0.0768 | 0.00000289 | 589 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000530 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity (PubMed:16387653, PubMed:27939640). Preferentially mediates histone H3-K23 acetylation (PubMed:27939640). Positively regulates the transcription of RUNX1 and RUNX2 (PubMed:18794358). {ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:18794358, ECO:0000269|PubMed:27939640}.;
- Disease
- DISEASE: Intellectual developmental disorder with dysmorphic facies and ptosis (IDDDFP) [MIM:617333]: An autosomal dominant neurodevelopmental disorder characterized by delayed psychomotor development, intellectual disability, delayed language, and facial dysmorphisms, most notably ptosis. Additional features may include poor growth, hypotonia, and seizures. {ECO:0000269|PubMed:27939639, ECO:0000269|PubMed:27939640}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Chromatin modifying enzymes;HATs acetylate histones;Chromatin organization;Regulation of TP53 Activity through Acetylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53
(Consensus)
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- loftool
- 0.252
- rvis_EVS
- -2.26
- rvis_percentile_EVS
- 1.27
Haploinsufficiency Scores
- pHI
- 0.622
- hipred
- Y
- hipred_score
- 0.765
- ghis
- 0.630
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.837
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Brpf1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- brpf1
- Affected structure
- hypobranchial 2 cartilage
- Phenotype tag
- abnormal
- Phenotype quality
- aplastic
Gene ontology
- Biological process
- histone H3 acetylation;histone H3-K23 acetylation;positive regulation of transcription, DNA-templated;regulation of signal transduction by p53 class mediator
- Cellular component
- nucleus;nucleoplasm;cytoplasm;cytosol;plasma membrane;MOZ/MORF histone acetyltransferase complex
- Molecular function
- DNA binding;protein binding;histone acetyltransferase activity (H3-K23 specific);metal ion binding